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Abstract
Genome-wide association studies (GWAS) are now used routinely to identify SNPs associated with complex human
phenotypes. In several cases, multiple variants within a gene contribute independently to disease risk. Here we introduce a
novel Gene-Wide Significance (GWiS) test that uses greedy Bayesian model selection to identify the independent effects
within a gene, which are combined to generate a stronger statistical signal. Permutation tests provide p-values that correct
for the number of independent tests genome-wide and within each genetic locus. When applied to a dataset comprising 2.5
million SNPs in up to 8,000 individuals measured for various electrocardiography (ECG) parameters, this method identifies
more validated associations than conventional GWAS approaches. The method also provides, for the first time, systematic
assessments of the number of independent effects within a gene and the fraction of disease-associated genes housing
multiple independent effects, observed at 35%–50% of loci in our study. This method can be generalized to other study
designs, retains power for low-frequency alleles, and provides gene-based p-values that are directly compatible for
pathway-based meta-analysis.
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Introduction
Traditional single-SNP GWAS methods have been remarkably
successful in identifying genetic associations, including those for
various ECG parameters in recent studies of PR interval (the
beginning of the P wave to the beginning of the QRS interval) [1],
QRS interval (depolarization of both ventricles) [2] and QT
interval (the start of the Q wave to the end of the T wave) [3–5].
Much of this success has relied upon increasing sample size
through meta-analyses across multiple cohorts, rather than
through the use of novel analytical methods to increase power.
One analytical approach, gene-based tests proposed during the
initial development of GWAS [6], has natural appeal. First,
variations in protein-coding and adjacent regulatory regions are
more likely to have functional relevance. Second, gene-based tests
allow for direct comparison between different populations, despite
the potential for different linkage disequilibrium (LD) patterns
and/or functional alleles. Third, these analyses can account for
multiple independent functional variants within a gene, with the
potential to greatly increase the power to identify disease/trait-
associated genes.
Despite these appealing properties, gene-based and related
multi-marker association tests have generally under-performed
single-locus tests when assessed with real data [7,8]. A general
drawback of methods that attempt to exploit the structure of LD to
reduce the number of tests, for example through principal
component analysis, is the loss of power to detect low-frequency
alleles. Methods that consider multiple independent effects often
require that the number of effects be pre-specified [9], which loses
power when the tested and true model are different.
Multi-locus tests often have the additional practical drawback of
being highly CPU and memory intensive. Several methods use
Bayesian statistics to drive a brute-force sum or Monte Carlo
sample over models [10,11], but again often restrict the search to
one or two-marker associations. In general, the computational
costs have made these approaches infeasible for genome-wide
applications.
The Gene-Wide Significance (GWiS) test addresses these
problems by performing model selection simultaneously with
parameter estimation and significance testing in a computational
framework that is feasible for genome-wide SNP data (see
Methods). Model selection, defined as identifying the best tagging
SNP for each independent effect within a gene, uses the Bayesian
model likelihood as the test statistic [12–14]. Our innovation is to
use gene regions to impose a structured search through locally
optimal models, which is computationally efficient and matches
the biological intuition that the presence of one causal variant
within a gene increases the likelihood of additional causal effects.
Models are penalized based on the effective number of in-
dependent SNPs within a gene and the number of SNPs in the
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Bayesian Information Criterion corrects for the difference between
the full model likelihood and the easily computed maximum
likelihood estimate [15]. This method has greater power than
current methods for genome-wide association studies and provides
a principled alternative to ad hoc follow-up analyses to identify
additional independent association signals in loci with genome-
wide significant primary associations.
Results
Reference genotype and phenotype data
The ECG parameters PR interval, QRS interval and QT
interval are ideal test cases because recent large-scale GWAS
studies have established known positive associations. These traits
are all clinically relevant, with increased PR interval associated
with increased risk of atrial fibrillation and stroke [16], and both
increased QRS and QT intervals associated with mortality and
sudden cardiac death [17–20]. We assessed the ability of standard
methods and GWiS to rediscover these known positives using data
from only the Atherosclerosis Risk in Communities (ARIC) cohort,
which contributes 15% of the total sample size for QRS, 25% for
PR, and 50% for QT (Table 1).
The SNPs were assigned to genes based on the NCBI Homo
sapiens genome build 35.1 reference assembly [21]. Gene boun-
daries were defined by the most 5’ transcriptional start site and 3’
transcriptional end position for any transcript annotated to a gene,
yielding 25,251 non-redundant transcribed gene regions. Incor-
porating additional flanking sequence increases coverage of more
distant regulatory elements, which increases power, but also
increases the number of SNPs tested, which decreases power.
Expression quantitative trait loci (eQTL) mapping in humans has
shown that most cis-regulatory SNPs are within 100 kb of the
transcribed region [22,23], with quantitative estimates that w93%
of large effect eQTNs (functional nucleotides that create eQTLs)
are within 20 kb of the transcribed region [24]. We report results
for 20 kb flanking regions; the performance ranking is robust to
flanking by up to 100 kb (Table S1). SNPs within these regions are
then assigned to one or more genes. Of the approximately 2.5
million genotyped and imputed SNPs, about 1.4 million are
assigned to at least one gene. The median number of SNPs per
gene is 43 and the mean is 72 (Table 1), reflecting a skewed
distribution with many small genes having few SNPs.
The ‘‘gold standard’’ known positives rely on previously
published meta-analyses of PR interval [1], QRS interval [2]
and QT interval [4,5]. We first identify gold-standard SNPs
having pv5|10{8. Any gene within 200 kb of a gold-standard
SNP is classified as a known positive, and known positives within a
200 kb window are merged into a single locus, yielding 38 known
positive gene-based loci. This procedure was followed to ensure
that each association signal results in a single locus as opposed to
being split between adjacent loci, which could result in over-
counting.
Other methods
The minSNP test uses the p-value for the best single SNP within
a gene. The minSNP-P test converts this SNP-based p-value to a
gene-based p-value by performing permutation tests within each
gene. BIMBAM averages the Bayes Factors for subsets of SNPs
within a gene, with restriction to single-SNP models recommended
for genome-wide applications [10]. Because the Bayes Factor sum
is dominated by the single best term, results for BIMBAM are
very similar to minSNP-P. The Versatile Gene-Based Test for
Genome-wide Association (VEGAS) [25] is a recent multivariate
method that sums the association signal from all the SNPs within a
gene and corrects the sum for LD to generate a test statistic. The
x2 terms summed by VEGAS are asymptotically equivalent to the
negative logarithms of the Bayes Factors summed by BIMBAM.
LASSO regression, or L1 regularized regression, is a multivariate
method that combines sparse model selection and parameter
optimzation [26–28], with promising recent applications to GWAS
[29]. See Methods for more details.
Simulated data and power
Power calculations used genotypes from the ARIC population
to ensure realistic LD. Phenotypes were then simulated for genetic
models with one or more causal variants within a gene. GWiS was
the best-performing method, with an advantage growing as more
Table 1. Populations, genes, and SNPs used in this study.
PR QRS QT
Individuals, published GWAS 28,517 47,797 15,842/13,685
Individuals, this study 7,076 7,250 7,771
Individuals, this study relative to
published
25% 15% 49%/57%
Genes, total 25,251
Genes, at least one SNP assigned 24,337
SNPs, total 2,557,232
SNPs, assigned to at least one gene 1,392,262
SNPs, average per gene 72
SNPs, median per gene 43
Effective tests, average per gene 9.3
Effective tests, median per gene 7.3
For SNP assignment, gene regions are defined to include 20 kb flanking
transcription boundaries.
doi:10.1371/journal.pgen.1002177.t001
Author Summary
Genome-wide association studies (GWAS) have successful-
ly identified genetic variants associated with complex
human phenotypes. Despite a proliferation of analysis
methods, most studies rely on simple, robust SNP–by–SNP
univariate tests with ever-larger population sizes. Here we
introduce a new test motivated by the biological
hypothesis that a single gene may contain multiple
variants that contribute independently to a trait. Applied
to simulated phenotypes with real genotypes, our new
method, Gene-Wide Significance (GWiS), has better power
to identify true associations than traditional univariate
methods, previous Bayesian methods, popular L1 regular-
ized (LASSO) multivariate regression, and other approach-
es. GWiS retains power for low-frequency alleles that are
increasingly important for personal genetics, and it is the
only method tested that accurately estimates the number
of independent effects within a gene. When applied to
human data for multiple ECG traits, GWiS identifies more
genome-wide significant loci (verified by meta-analyses of
much larger populations) than any other method. We
estimate that 35%–50% of ECG trait loci are likely to have
multiple independent effects, suggesting that our method
will reveal previously unidentified associations when
applied to existing data and will improve power for future
association studies.
Gene-Based Tests of Association
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should have lower power than single-SNP tests when the true
model is a single effect; according to the ‘‘no free lunch theorem’’,
this loss of power cannot be avoided [30]. The performance of
GWiS therefore depends on the genetic architecture of a disease or
trait: higher power if genes house multiple independent causal
variants, and lower power if each gene has only a single causal
variant. In practice, the loss of power was so slight as to be virtually
undetectable.
Of the other methods, minSNP-P and BIMBAM had similar
performance that degraded as the true model included more
SNPs. The VEGAS test did not perform well, presumably because
the sum over all SNPs creates a bias to find causal variants in LD
blocks represented by many SNPs and to miss variants in LD
blocks with few SNPs. In the absence of LD, with genotypes and
phenotype simulated using PLINK [31], VEGAS performs better
(Figure S1). The LASSO method performed worst.
The advantage of GWiS arises in part from better power to
detect associations with low-frequency alleles (Figure 1b). GWiS,
minSNP-P, and BIMBAM have roughly constant power for a
given variance explained, regardless of minor allele frequency. In
contrast, both VEGAS and LASSO suffer from a two-fold loss of
power when minor allele frequencies drop from 50% to 5%.
VEGAS may lose power because these low-frequency SNPs lack
correlation with other SNPs, reducing the contribution to the
VEGAS sum statistic. The LASSO penalty shrinks the regression
coefficient, which may adversely affect SNPs with large regression
coefficients that balance low minor allele frequencies.
Simulated data and model size
The model size selected by GWiS and LASSO was evaluated by
simulation (Figure 2). These simulations also used the ARIC
population to supply realistic LD, with genes selected at random
with replacement from chromosome 1. In chromosome 1, the
number of SNPs in a gene ranges from 1 to over 1000, and the
number of independent effects ranges from 1 to over 100, similar
to the distributions in the genome as a whole (Figure S2). A subset
of SNPs within a gene had causal effects assigned (‘‘True K’’),
phenotypes were simulated to mimic weak and strong gene-based
signals, and then models were selected by GWiS and LASSO.
Model selection to retain a subset of SNPs (‘‘Estimated K’’) was
performed both for the full genotype data and for the genotype
data with the causal SNPs all removed.
GWiS provides a better estimate of the true model size than
LASSO, assessed from the R2 of estimated versus true K. With
causal SNPs kept, R2 for GWiS is substantially higher, 0.65 versus
0.47 at low power (Figure 2a, 2c) and 0.81 versus 0.60 at high
power (Figure 2b, 2d). GWiS also performs better when causal
SNPs are removed, 0.55 versus 0.33 at low power and 0.60 versus
0.39 at high power. GWiS also provides a conservative estimate of
the model size, with the ratio of estimated to true size ranging from
a worst-case of 44% (low power, causal SNPs removed) to a best-
case of 81% (high power, causal SNPs kept) over the four scenarios
examined. In contrast, LASSO is prone to over-predict the size of
the model, with a worst-case of models that are on average 33%
too large (high power, causal SNPs kept, Figure 2d).
Removing a causal SNP results in GWiS predicting a smaller
model, with the ratio of estimated to true K dropping from 0.55 to
0.44 for low power and from 0.85 to 0.81 for high power. These
reductions in model size are highly significant (p v2|10{16 for
both, Wilcoxon pair test) and counter a concern that the absence
of a causal variant from a marker set will inflate the model size by
introducing multiple markers that are partially correlated with the
untyped causal variant.
These results demonstrate that the model size returned by
GWiS is conservative for causal variants with small effects, and
approaches the true model size for causal variants with large
effects.
Application to ECG data
We then obtained p-values from GWiS, minSNP, minSNP-P,
BIMBAM, VEGAS, and LASSO for the ARIC data. Permutations
Figure 1. Estimated power at genome-wide significance for simulated data. Power estimates for GWiS (black), minSNP-P (blue), BIMBAM
(dashed blue), VEGAS (green), and LASSO (red) are shown for 0.007 population variance explained by a gene. Genes were selected at random from
Chr 1; genotypes were taken from ARIC; and phenotypes were simulated according to known models with up to 8 causal variants with independent
effects. (a) Power decreases as total variance is diluted over an increasing number of causal variants. (b) Power estimates with 95% confidence
intervals are shown as a function of minor allele frequency (MAF) for the simulations from panel (a) with a single independent effect. GWiS, minSNP,
minSNP-P, and BIMBAM are robust to low minor allele frequency, whereas VEGAS and LASSO lose power.
doi:10.1371/journal.pgen.1002177.g001
Gene-Based Tests of Association
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thresholds for genome-wide significance for each method (Table
S2). Due to LD across genes, a strong signal in one gene can lead to
a neighboring gene reaching genome-wide significance. This effect
is well known, and scoring these as false positives would unduly
penalize traditional univariate tests. Instead, neighboring genes
reaching genome-wide significance were merged, and overlap
(even partial) with a known positive was scored as a true positive.
GWiS out-performed all other methods in the comparison
(Figure 3 and Table 2). GWiS identifies 6 of 38 known genes or
loci as genome-wide significant. In contrast, BIMBAM identifies 5
known positives; minSNP, minSNP-P and VEGAS identify 4; and
LASSO identifies 2. Loci identified by the other methods are all
subsets of the 6 found by GWiS. None of the methods produced
any false positives at genome-wide significance.
Due to the limited size of the ARIC cohort relative to the studies
that generated the known positives, no method was expected to
find all 38 known loci to be genome-wide significant. Nevertheless,
known positives should still rank high among the top predictions of
each method, assessed by the ranks of the known positives at 40%
recall (Figure S3). We found that GWiS, minSNP, minSNP-P,
BIMBAM, and VEGAS were equally effective in ranking known
positives (Mann-Whitney rank sum p-values §0:78 for any
pairwise comparison). LASSO performed below the other
methods (p-value ƒ0:04 for a pairwise comparison of LASSO
to any other method). Top associations (up to 100 false positives)
from each method are provided for PR interval, QRS interval,
and QT interval (Tables S3, S4, S5).
While our conclusions are based on cardiovascular phenotypes,
the results suggest that GWiS will have an advantage when causal
genes have multiple effects. When an association is sufficiently
strong to be found by a univariate test, GWiS is generally able to
identify it. Beyond these association, GWiS is also able to detect
genes that are genome-wide significant, but where no single effect
is large enough to be significant by univariate tests. The asso-
ciation of QRS interval with SCN5A-SCN10A is a striking
example: 4 independent effects are found by GWiS (p-value
=3:4|10{12) butthe associationisnotgenome-wide significant by
univariate methods (p-value=4:4|10{5 for minSNP-P) (Figure 4).
A common follow-up strategy for single-SNP methods is to search
for secondary associations in the same locus as a strong primary
association. These results for ARIC together with results above for
simulated data (Figure 2) demonstrate that GWiS performs this
task well. While this feature is present in previous follow-up
methods for candidate loci [11,33,34], it is absent from methods
generally used for primary analysis of GWAS data.
Figure 2. Model size estimation. The ability to recover the known model size was evaluated for GWiS (a and b) and LASSO (c and d). The power to
detect a single SNP was set to be 10% (a and c) and 80% (b and d). In separate tests, the causal SNPs were either retained in (black) or removed from
(red) the genotype data.
doi:10.1371/journal.pgen.1002177.g002
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one SNP (regardless of genome-wide significance), and 7 of these
are predicted to have multiple independent effects (Figure 5).
These results suggest that the genetic architecture of ECG traits
supports the hypothesis underlying GWiS. Moreover, for QT
interval where the power is greatest to identify known positives (the
ARIC sample size is 50% of the GWAS discovery cohorts), 5 of
the 10 loci identified by GWiS are predicted to have multiple
independent effects.
Discussion
In summary, we describe a new method for gene-based tests of
association. By gathering multiple independent effects into a single
test, GWiS has greater power than conventional tests to identify
genes with multiple causal variants. GWiS also retains power for
low-frequency minor alleles that are increasingly important for
personal genetics, a feature not shared by other multi-SNP tests.
Furthermore, GWiS provides an accurate, conservative estimate
for the number of independent effects within a gene or region.
Currently there are no standard criteria for establishing the
genome-wide significance of a weak second association in a gene
whose strongest effect is genome-wide significant. While the
number of effects can be provided by existing Bayesian methods
[34], their computational expense has limited their applicability to
candidate regions, and they are not routinely used. By providing a
computationally efficient alternative to existing methods, GWiS
provides a new capability to estimate the number of effects as part
of primary GWAS data analysis. Demonstrated effectiveness on
real data may lead to more widespread use of this type of analysis.
Applied to cardiovascular phenotypes relevant to sudden cardiac
death and atrial fibrillation, GWiS indicates that 35 to 50% of all
known loci contain multiple independent genetic effects.
The test we describe includes a prior on models designed to be
unaffected by SNP density, in particular by the number of SNPs
that are well-correlated with a causal variant. The priors on
regression parameters are essentially uniform, with the benefit of
eliminating any user-adjustable parameters. A theoretical draw-
back is that the priors are improper [35,36]. Theoretical concerns
are mitigated, however, because improper priors pose no challenge
for model selection, and our permutation procedure ensures
uniform p-values under the null.
Bayesian methods can be computationally expensive. GWiS
minimizes computation by evaluating only the locally optimal
models of increasing size in a greedy forward search. This appears
to be an approximation compared to previous Bayesian methods
that sum over all models. Previous Bayesian methods entail their
own approximations, however, because the search space must
either be truncated at 1 or 2 SNPs, heavily pruned, or lightly
sampled using Monte Carlo. Our results demonstrate that the
Figure 3. Recovery of known positive associations at genome-wide significance. Of 38 known positives, GWiS identified 6 at genome-wide
significance with no false positives. Univariate methods (minSNP and minSNP-P) and VEGAS identified a subset of 4 entirely contained by GWiS, and
LASSO identified a smaller subset of 2.
doi:10.1371/journal.pgen.1002177.g003
Gene-Based Tests of Association
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efficiency than approximations used in previous Bayesian
frameworks, with no loss of statistical power. GWiS currently
calculates p-values, rather than Bayesian evidence provided by
other Bayesian methods. If Bayesian evidence is desired, an
intriguing alternative to Bayesian post-processing of candidate loci
might be to use the Bayes Factor from the most likely alternative
model identified by GWiS as a proxy for the sum over all
alternatives to the null model. This may be an accurate ap-
proximation because, in practice, the Bayes Factor for the most
likely model from GWiS dominates all other Bayes Factors in the
sum.
The GWiS framework, using gene annotations to structure
Bayesian model selection, may be applied to case-control data by
encoding phenotypes as 1 (case) versus 0 (control), a reasonable
approach when effects are small. More fundamental extensions to
logistic regression, Transmission Disequilibrium Tests (TDTs),
and other tests and designs should be possible and may yield
further improvements. Moreover, similar gene-based structured
searches can be applied to genetic models to include explicit
interaction terms [14]. The Bayesian format also permits
incorporation of prior information about the possible functional
effects of SNPs [37,38], and disease linkage [39,40]. Finally, the
gene-based p-values provide a natural entry to gene annotations
and pathway-based gene set enrichment analysis [41–43].
Materials and Methods
Ethics statement
This research involves only the study of existing data with
information recorded in such a manner that the subjects cannot be
identified directly or through identifiers linked to the subjects.
Known positives
Known positive associations are taken from published genome-
wide significant SNP associations (p-value v5|10{8) [1,2,4,5].
Genes within 200 kb of any genome-wide significant SNP are
scored as known positives. Finally, genes within 200 kb that are
both positive are merged into a single known positive locus to
avoid over-counting.
Study cohort
The ARIC study includes 15,792 men and women from four
communities in the US (Jackson, Mississippi; Forsyth County,
North Carolina; Washington County, Maryland; suburbs of
Minneapolis, Minnesota) enrolled in 1987-89 and prospectively
followed [44]. ECGs were recorded using MAC PC ECG
machines (Marquette Electronics, Milwaukee, Wisconsin) and
initially processed by the Dalhousie ECG program in a central
laboratory at the EPICORE Center (University of Alberta,
Edmonton, Alberta, Canada) but during later phases of the study
using the GE Marquette 12-SL program (2001 version) (GE
Marquette, Milwaukee, Wisconsin) at the EPICARE Center
(Wake Forest University, Winston-Salem, North Carolina). All
ECGs were visually inspected for technical errors and inadequate
quality. Genotype data sets were cleaned initially by discarding
SNPs with Hardy-Weinberg equilibrium violations at p v
0:00001, minor allele frequencies v0:01, or call rates v0:95.
Imputation with HapMap CEU reference panel version 22 was
then performed, and all imputed SNPs were retained for analysis,
included imputed SNPs with minor-allele frequencies as low as
0.001. These cleaned data sets contributed to the meta-analysis to
yield the known positives, and full descriptions of phenotype and
sample data cleaning are available elsewhere [1,2,4]. Regional
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PLoS Genetics | www.plosgenetics.org 7 July 2011 | Volume 7 | Issue 7 | e1002177Figure 4. Multiple weak effects identified as genome-wide significant. GWiS correctly identifies the SCN5A-SCN10A locus as genome-wide
significant with four independent effects, even though the strongest single effect has a p-value 100| worse than the genome-wide significance
threshold indicated as a dashed line. No other method was able to identify this locus as genome-wide significant. The SNPs selected by GWiS are
represented as large, colored diamonds, and SNPs in LD with these four are colored in lighter shades. The light blue trace indicates recombination
hotspots.
doi:10.1371/journal.pgen.1002177.g004
Figure 5. Distribution of the number of independent effects in ECG loci. Of 38 known positive loci, GWiS identified 20 loci, and 7 of these
contain multiple independent effects.
doi:10.1371/journal.pgen.1002177.g005
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‘‘make.fancy.locus.plot’’ [45].
Conventional multiple regression
The phenotype vector Y for N individuals is an N|1 vector of
trait values. The genotype matrix X has N rows and P columns,
one for each of P genotyped markers assumed to be biallelic SNPs.
For simplicity, the vector Y and each column of X are stan-
dardized to have zero mean. A standard regression model esti-
mates the phenotype vector as Y~Xbze, where b is a vector of
regression coefficients and e is a vector of residuals assumed to be
independent and normally distributed with mean 0 and variance
s2 . The log probability of the phenotypes given these parameters is
logPr(Yjb,s2,X)~{
1
2
N ln(2p)zN ln(s2)z
jY{Xbj
2
s2
()
:ð1Þ
The maximum likelihood estimators (MLEs) are ^ s s2~
jY{Xbj
2=N and ^ b~(X’X)
{1X’Y, where X’ denotes the trans-
pose of X. The total sum-of-squares (SST) is jYj
2, and the sum-of-
squares of the model (SSM) is j^ Yj
2~Y’X(X’X)
{1X’Y . The sum-
of-squares of the errors or residuals (SSE) is
SSE~SST{SSM~jY{X^ bj
2~jYj
2{j^ Yj
2: ð2Þ
A conventional multiple regression approach uses the F-statistic
to decide whether adding a new SNP improves the model
significantly,
F~
SSM=K
SSE=(N{K{1)
ð3Þ
for a model with K SNPs, distributed as F(K,N{K{1) under the
null. This approach fails, however, when the best K SNPs are
selected from the much larger number of M total SNPs, because
the F statistic does not account for the selection process.
Bayesian model selection
A model M is defined as the subset of K SNPs in a gene with P
total SNPs that are permitted to have non-zero regression
coefficients. For each gene, GWiS attempts to find the subset that
maximizes the model probability Pr(MjY,X), where each of the P
columns of X corresponds to a SNP assigned to the gene. In the
absence of association, the null model with K =0 usually maximizes
the probability, indicating no association. When a model withKw0
maximizes the probability, an association is possible, and permu-
tation tests provide a p-value. According to Bayes rule,
Pr(MjY,X)~Pr(YjM,X)Pr(M)=Pr(Y): ð4Þ
The factor Pr(Y) is model-independent and can be ignored.
The prior probability of the model, Pr(M), assumes that each of
the P SNPs within the gene has an identical probability of being
associated with the trait. This probability, denoted f, is unknown,
andisintegrated out witha uniformprior. The prioris alsodesigned
to make the model probability insensitive to SNP density: it should
be unaffected if an existing SNP is replicated to create a new SNP
marker with identical genotypes. We do this by replacing the
number of SNPs within a gene with an effective number of tests, T,
calculated from the local LD within a gene. Correlations between
SNPs make the effective number of tests smaller than the number of
SNPs. The model prior based on the effective number of tests is
Pr(M)~
ð1
0
f K(1{f)
T{Kdf:Beta(Kz1,T{Kz1), ð5Þ
or K!(T{K)!=(Tz1)! for integer values. As the effective number
of tests, T, whose calculation is described below, is generally non-
integer, we use the standard Beta function rather than factorials.
The remaining factor in Eq. 4 is
Pr(YjM,X)~
(ABK)
{1
ðA
0
dt
ðB=2
{B=2
db(t=2p)
N=2 exp½{(t=2)jY{Xbj
2 :
ð6Þ
The integration limits and prefactor 1=ABK ensure normaliza-
tion. We assume that these limits are sufficiently large to permit a
steepest descents approximation as in Schwarzian BIC model
selection [15]. First, assuming that the genotypes are centered, the
genotype covariance matrix is
XX
X0X=N, where 0 indicates
matrix transpose as before, and diagonal elements Skk&
2pk(1{pk) for SNP k with allele frequency pk. Provided that B
is much greater than each component of ^ b~(X0X)
{1X0Y, the
integral over b is approximately
Pr(YjM,X)~
(ABK det
X1=2
)
{1N{K=2
ðA
0
dt(t=2p)
(N{K)=2 exp½{(t=2)SSE ,
ð7Þ
where the sum-squared-error SSE is jY{X^ bj
2. Provided that the
limit A is much greater than the maximum likelihood value
~ t t~(N{K)=SSE:1=~ s s2, the integral over t can be approximated as
ðA
0
dt(t=2p)
(N{K)=2 exp½{(t=2)SSE &
(2=SSE)
1z(N{K)=2(1=2p)
(N{K)=2C½1z(N{K)=2 ,
ð8Þ
where C(x) is the standard Gamma function. To avoid the cost of
Gamma function evaluations, we instead use the steepest descents
approximation,
ðA
0
dt(t=2p)
(N{K)=2 exp½{(t=2)SSE &
½2p=(N{K)~ s s4 
1=2(1=2p~ s s2)
(N{K)=2e{(N{K)=2:
ð9Þ
The log-likelihood is then
lnPr(YjM,X)~{½(N{K)=2 ½1zln(2p~ s s2) {(K=2)lnN
{ln(ABK det
X1=2
)z(1=2)ln½2p=(N{K)~ s s4 : ð10Þ
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on the model and are of order lnN or greater. Thus we replace
N{K by N, and ~ s s2&^ s s2. For historical reasons, we also included
a factor of (2p)
K=2 in the prior for model size, to yield the
asymptotic approximation
lnPr(YjM,X)&{(N=2)½1zln(2p^ s s2) {(K=2)ln(N=2p): ð11Þ
The strategy of GWiS is therefore to find the model that
maximizes the objective function
Pr(MjY,X)&{(N=2)½1zln(2p^ s s2) {
(K=2)ln(N=2p)zlnBeta(Kz1,T{Kz1):
ð12Þ
The terms involving K provide a Bayesian penalty for model
performance, but also make this an NP-hard optimization
problem. We have adopted two efficient deterministic heuristics
for approximate optimization. First is a greedy forward search,
essentially Bayesian regularized forward regression, in which the
SNP giving the maximal increase to the model likelihood is added
to the model sequentially until all remaining SNPs decrease the
likelihood. The second is a similar heuristic, except that the initial
model searches through all subsets of 2 SNPs or 3 SNPs. We
adopted this subset search to permit the possibility that all K =1
models are worse than the K =0 null, whereas a more complex
model with K~2 or 3 has higher score. In practice, all associations
identified by subset selection were also identified by greedy
forward search. We therefore used the greedy forward search for
computational efficiency.
GWiS is designed to select a single model for each gene. An
alternative related approach would be to test for the posterior
probability of the null model, Pr(noSNPsjdata), against all other
models, Pr(1SNPjdata) + Pr(2SNPsjdata) + Pr(3SNPsjdata) +
..., using our model selection procedure either to choose the
locally best model of each size or to include multiple models
(which could suffer from a systematic bias favoring SNPs in large
LD blocks). This is in fact the strategy of BIMBAM, which
attempts to systematically evaluate all terms up to a given model
size. Unfortunately, the number of terms increases exponentially
fast with model size, and the brute-force approach does not scale
to genome-wide applications. Monte Carlo searches over models
have also been difficult to apply genome-wide. Our work suggests
that approximations that limit the search for fixed model size can
be accurate, and further that the probabilities of models that are
too large are expected to decrease exponentially fast, permitting
the sum to be pruned and truncated. We have observed in practice
that the model with the most likely value of K dominates the sum,
and similarly for BIMBAM that the single SNP with the best Bayes
Factor dominates the sum-of-Bayes-Factors test statistic. These
results suggest that the results of a more computationally expensive
sum over all models would be largely consistent with the results of
GWiS method. Furthermore, the Bayes Factor for the most likely
model could provide a proxy for the Bayesian evidence.
Effective number of tests
The effective number of tests is an established concept in
GWAS to provide a multiple-testing correction for correlated
markers. While the exact correction can be established by
permutation tests, faster approximate methods can perform well
[46–49]. While we use a fast procedure, a final permutation test
ensures that p-values are uniform under the null.
The method we adopt is based on multiple linear regression of
SNPs on SNPs. The genotype vector xi for each SNP i is
standardized to have zero mean. Correlations between all pairs of
SNPs i and j are initialized as Cij~xi
0xj=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
jxijjxjj
p
. Each SNPs
weight wi is initialized to 1, and the number of effective tests T is
initialized to 0. The SNP i with maximum weight is identified, and
the following updates are executed:
T/Tzwi
wj/max(wj{C2
jiwi,0) for all SNPs j: ð13Þ
This process continues until all weights are equal to zero.
When SNPs with maximum weight are tied (as occurs for the first
SNP processed), the SNP with lowest genomic coordinate is
selected to ensure reproducibility; we have ensured that this
method is robust to other methods for breaking ties, including
random selection. For simplicity, the correlations are not updated
(the update rule would be Cjk/max½Cjk{CjiCki=wi,0 ), which
may lead to an overestimate for T. Model selection may therefore
have a conservative bias. The p-values are not affected, however,
because they are calculated by permutation tests as described
below.
The effective number of tests implies a trivial renormalization of
the model prior, (Eq. 5), that does not affect the test statistic.
Letting T be the total number of markers, N be the effective
number tests, and K be the size of the model, our prior gives each
model of size K the weight ½(Nz1)C(N,K) 
{1.I fN and T are
identical, there are C(N,K) models of this size, and the total
weight of all models of size K is 1=(Nz1). Since K can range
from 0 to N, the sum is normalized. But when T is larger than N,
the sum of all models of size K is C(T,K)=(Nz1)C(N,K), which
is §1=(Nz1). The sum from K~0 to T is therefore
§(Tz1)=(Nz1)§1. A normalization of 1 can be recovered
by including an overall normalization factor, Q~(Nz1)
{1
XN
K~0 C(T,K)=C(N,K). The explicit prior for models of size
K is Pr(K)~½Q(Nz1)C(N,K) 
{1, which is normalized to 1.
Since Q is model-independent, it does not contribute to the test
statistic.
P-values and genome-wide significance
We use two stages of permutation tests: the first stage converts
the GWiS test statistic into a p-value that is uniform under the
null; the second stage establishes the p-value threshold for genome-
wide significance.
The first stage is conducted gene-by-gene. We permute the trait
array using the Fisher-Yates shuffle algorithm [50,51] and use the
permuted trait to calculate the test statistics using the same
procedure as for the original trait. Specifically, the model size K is
optimized independently for each permutation, with most per-
mutations correctly choosing K =0. For S successes (log-likeli-
hoods greater than or equal to the unpermuted phenotype data)
out of Q permutations, the empirical p-value is S/Q. To save
computation, permutations are ended when S§10. Furthermore,
once a finding is genome-wide significant, there is no practical
need for additional permutations. For gene-based tests (GWiS,
minSNP-P, BIMBAM, and VEGAS), the p-value for genome-wide
significance depends on the number of genes tested (rather than
the number of SNPs),
p=10{5 for humans. We therefore also terminate permutations
after Q=1 million trials, regardless of S. In these cases, for
Gene-Based Tests of Association
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P½F(SSM=SSE,K,T{K{1) |C(T,K): ð14Þ
The first factor is the parametric p-value for the F statistic from
the MLE fit, and the second term is the combinatorial factor for
the number of possible models of the same size.
While these p-values are uniform under the null, the threshold
for genome-wide significance requires a second set of permuta-
tions. To establish genome-wide significance thresholds, in the
second stage we permuted the ARIC phenotype for each trait 100
times, ran GWiS for the permuted phenotypes on the entire
genome, and recorded the best genome-wide p-value from each of
the 100 permutations. We then combined the results from each
trait to obtain an empirical distribution of the best genome-wide p-
value under the null. We then estimated the p=0.05 genome-wide
significance threshold as the 15th best p-value of the 300.
This procedure was performed for GWiS, minSNP, minSNP-P,
LASSO, and VEGAS to obtain genome-wide significance
thresholds for each. Since minSNP-P and BIMBAM are both
uniform under the null, we used the genome-wide significance
threshold calculated for minSNP-P, 3|10{6, for BIMBAM to
avoid additional computional cost (Table S2). The threshold for
GWiS is more stringent, 2|10{6, presumably because of the locus
merging procedure described below. Changes in the genome-wide
significance thresholds of up to 50% would not affect any of the
reported results.
Hierarchical analysis of genetic loci
In a region with a strong association and LD, GWiS can
generate significant p-values for multiple genes in a region. A
hierarchical version of GWiS is used to distinguish between two
possibilities. First, through LD, a strong association in one gene
may cause a weaker association signal in a second gene. In this
case, only the strong association should be reported. Second, the
causal variant may not be localized in a single gene; for example,
the best SNP tags are assigned to multiple genes. In this case, the
individual genes should be merged into a single associated locus.
The hierarchical procedure is as follows.
1. Identify all genes with GWiS pƒ0:01, and use transitive
clustering to merge into a locus all genes whose transcript
boundaries are within 200 kb.
2. Run GWiS on the merged locus (including a recalculation of
the number of effective tests within the locus) and identify the
SNPs selected by the GWiS model. If genes at either end of the
locus have no GWiS SNPs, trim these genes from the locus.
Repeat this step until no more trimming is possible. If only a
single gene remains, accept it with its original p-value as the
only association in the region. Otherwise, proceed to step 3.
3. Use a permutation test to calculate the p-value for the merged
locus from step 2. Assign it a p-value equal to the minimum of
the p-values from the individual genes, and the p-value from its
own permutation. Regardless of the p-value used, retain the
entire trimmed region as an associated locus.
The trimming in step 2 handles the first possibility, a strong
association in one gene that causes a weaker association in a
neighbor. The rationale for accepting the smallest p-value in step 3
is the case of a single SNP assigned to multiple genes. The merged
region will have a less significant p-value than any single gene, and
it does not seem reasonable to incur such a drastic penalty for gene
overlap.
Univariate tests: minSNP and minSNP-P
For these tests, SNPs are assigned to gene regions as before. The
p-value for each SNP is then calculated using the F-statistic as the
test statistic, with empirical p-values from permutation to ensure
correct p-values for SNPs with low minor allele frequencies. The
minSNP method assigns a gene the p-value of its best SNP.
Selection of the best p-value out of many leads to non-uniform p-
values under the null. It is standard to reduce this bias by scaling p-
values by a Bonferroni correction based on the number of SNPs or
number of estimated tests. Instead, we perform gene-by-gene
permutation tests using the best F statistic for SNPs within the gene
as the test statistic. As with GWiS, if 1 million permutations do not
lead to one success, the association is clearly genome-wide sig-
nificant and we use the Bonferroni-corrected p-value for ranking
purposes.
BIMBAM
The Bayesian Imputation-based Association Mapping (BIM-
BAM) is a Bayesian gene-based method [10]. BIMBAM calculates
the Bayes Factor for a model and then averages the Bayes Factors
for all models within a gene to obtain a test statistic. Because 1-
SNP models were found to have as much power as 2-SNP models,
and because 2-SNP models are not computationally feasible for
genome-wide analysis, BIMBAM by default restricts its sum to all
1-SNP models within a gene [10]. The Bayes Factor BF(i) for a
single SNP i is
BF(i)~Pr(YjX)=Pr(Y) ð15Þ
~jVj
1=2N1=2s{1
a
Y0Y{B0V
{1B
Y0Y{N   Y Y2
   {N=2
:
The design matrix X has first column 1s and second column
equal to the dosages of SNP i in the N individuals;   Y Y is the
phenotypic mean; V~(tzX0X)
{1; the matrix t is diagonal with
diagonal terms (0,s{2
a ); and B contains the regression coefficients
B~VX0Y. We used the recommended value sa~0:2 relative to
the phenotypic standard deviation. The test statistic for a gene
with T SNPs is T{1 XT
i~1 BF(i). As with other methods, we used
gene-by-gene permutations to convert this statistic into a p-value
that is uniform under the null. Up to 1 million permutations were
used, stopping after 10 successes.
The sufficient statistics used by BIMBAM are identical to
minSNP and minSNP-P, yet we found that the runtime of the
public implementation was much slower, taking 270 sec for 1000
permutations of a gene with 135 SNPs across 8000 individuals. By
improving memory management and optimizing computations,
we improved the timing to 14 sec per 1000 permutations, a 19-fold
speed-up. This implementation is included in our Supplementary
Materials.
VEGAS
The Versatile Gene-Based Test for Genome-wide Association
(VEGAS) [25] is a recently proposed method that considers the
SNPs within a gene as candidates for association study. VEGAS
assigns SNPs to each of the autosomal genes using the UCSC
genome browser hg18 assembly. The gene boundaries are defined
as +50kb of the 5’ and 3’ UTRs. Single SNP p-values are used to
compute a gene-based x2 test statistic for each gene and sig-
nificance of each gene is evaluated using simulations from a
Gene-Based Tests of Association
PLoS Genetics | www.plosgenetics.org 11 July 2011 | Volume 7 | Issue 7 | e1002177multivariate normal distribution with mean 0 and covariance
matrix being the pairwise LD values between the SNPs from
HapMap Phase 2. As a result the method avoids permutations in
calculating per gene p-values, although permutations are required
to obtain the genome-wide significance threshold.
LASSO regression
LASSO regression is a recent method for combined model
selection and parameter estimation that maps L1 regularized
regression onto a computationally tractable quadratic optimization
problem [26–28]. Applications to GWAS are attractive because it
is possible to perform model selection on an entire chromosome.
We therefore implemented a recent LASSO procedure developed
specifically for GWAS [29].
To reduce computational cost, univariate p-values are estimated
from parametric tests, and gene-based SNPs with pv0:001 are
retained (we have confirmed that this computational constraint
does not lose any known positive associations). Incremental model
selection was performed by Least Angle Regression [27] using the
R lars package [52]. The LASSO parameter was determined using
5-fold cross validation. All genes with at least one SNP selected
were identified, and selected genes overlapping other selected
genes (including flanking regions) were merged into single loci.
As suggested previously, we used the Selection Index to rank
genes and as the test statistic for a permutation p-value [29]. To
obtain the Selection Index, the MLE log-likelihood is calculated
for the full model and for a reduced model with a subset of SNPs
removed. Twice the log-likelihood difference is interpreted as a x2
statistic, and the Selection Index is defined as the corresponding p-
value for a x2 distribution with the number of removed SNPs as
the degrees of freedom. Due to the LASSO model selection
procedure, the Selection Index is not distributed as a x2 under the
null, and permutation tests are used to establish genome-wide
significance levels.
Simulations: power
For each true model size of K~1 to 8, we performed a series of
simulations by picking 1000 genes from chromosome 1 randomly
with replacement, using genotype data from the ARIC population
of approximately 8000 individuals. For each gene, we selected K
‘‘causal’’ SNPs that have R2v0:5 from regression with other
‘‘causal’’ SNPs within the gene. A gene had to have at least 2K
SNPs to be picked for models of size K to ensure enough
remaining SNPs after the removal of the causal SNPs to permit a
model of the true size.
We attempted to distribute the total population variance
explained, V~0:007, equally across the K SNPs. The covariance
matrix for the SNPs calculated from the population is denoted S,
with S{1
ij understood to be (S{1)ij. The coefficient bk for SNP k
in the model was set to
bk~+
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
V=
X K
i,j~1
S
1=2
ii S{1
ij S
1=2
jj
v u u t :
X K
l~1
S{1
kl S
1=2
ll , ð16Þ
which ensures that var(Xb)~V. The phenotype Y for an
individual with genotype row-vector X was then calculated as
Y~(X{m):bzu
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{V
p
, with m again the population average of
X and u drawn from a standard normal distribution.
The power was calculated as (number of genes that are genome-
wide significant)/1000, and the error of the estimate was
calculated using 95% exact binomial confidence intervals. The
p-value thresholds were taken directly from genome-wide per-
mutations (Table 2).
Simulations: model size
Phenotypes that were used to estimate the model size were
generated by assigning each ‘‘causal’’ SNP the same power of 0.1
and 0.8. The population variance explained for each SNP was
calculated as V~(za{z1{power)
2=N, in which za is the quantile of
the standard normal for upper-tail cumulative probability of a,
and z1{power is the quantile for lower-tail probability 1{power.
We chose a to be 5|10{8, the commonly used genome-wide
significance threshold for univariate tests. The effect of SNP k is
then bk~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
V=Skk
p
, in which
P
is the genotype covariance
matrix. The simulated phenotypes are then (X{m)bzu
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{KV
p
,
with u drawn from a standard normal distribution. In this test we
control for the variance explained by the SNP, not by the gene,
and therefore do not rescale the regression coefficients to account
for LD. For each K ranging from 0 to 10, we repeated these steps
using ARIC genotype data for 100 genes chosen at random from
chromosome 1.
Only GWiS and LASSO give model size estimates. GWiS
directly reports the model size as the number of independent
effects within a gene and LASSO reports the model size as the
number of selected SNPs within a gene. We ran both methods
using the simulated data with LD. We also tested both scenarios
when the causal SNPs were kept or removed from gene.
Performance evaluation
Gene associations were scored as true positives if the gene (or
merged locus) overlapped with a known association, and as false
positives if no overlap exists. Only the first hit to a known
association spanning several genes was counted.
The primary evaluation criterion is the ability to identify known
positive associations at genome-wide significance. The genome-
wide significance threshold was determined separately for each
method (see above), and no method gave any false positives at its
appropriate threshold.
A secondary criterion was the ability to enrich highly ranked
loci for known associations, regardless of genome-wide signifi-
cance. This criterion was assessed through precision-recall curves,
with precision = TP/(TP+FP), recall = TP/(TP+FN), and true
positives (TP), false positives (FP), and false negatives (FN) defined
as a function of the number of predictions considered.
Small differences in precision and recall may not be statistically
significant. To estimate statistical significance, we performed
a Mann-Whitney rank sum test for the ranks of the known
associations at 40% recall for GWiS, minSNP, minSNP-P, and
LASSO.
Implementation
GWiS runs efficiently in memory and CPU time, roughly
equivalent to other genome-wide tests that require permutations
(Table 3). Computational times are greater for real data because
real associations with small p-values require more permutations.
LASSO required far less computational resources, but also pre-
filtered the SNPs and had the worst performance. Genome-wide
studies can be finished within around 100 hours. Low memory
requirements allow GWiS to run in parallel on multiple CPUs.
The GWiS source code implementing GWiS, minSNP, minSNP-
P, and BIMBAM is available under an open source GNU General
Public License as Supplementary Material, also from the authors’
website (www.baderzone.org), and is being incorporated into
PLINK [31].
Gene-Based Tests of Association
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Figure S1 Estimated power at genome-wide significance for
genotypes simulated without LD. Simulation tests were performed
for true models in which a single gene housed one to eight
independent causal variants. Genotypes were simulated with
20 SNPs per gene, no LD between SNPs, and minor allele
frequencies selected uniformly between 0.05 and 0.5. Power
estimates are provided for VEGAS (green), GWiS (black),
minSNP-P (blue), BimBam (blue dashed), and LASSO (red).
While VEGAS performs well in the absence of LD, its per-
formance degrades under realistic LD (see main text, Figure 1).
We simulated genetic models for quantitative traits with no linkage
disequilibrium between SNPs using the simulate-qt option of
PLINK. Genes were simulated with 20 SNPs and minor allele
frequencies selected uniformly between 0.05 and 0.5. Genotypes
were coded as allele dosages from 0 to 2. The power of a standard
regression test for additive effects depends on the population
variance explained, V~2p(1{p)b2 for a single variant with allele
frequency p and regression coefficient (or effect size) b.W e
performed simulations holding V constant and sampling different
allele frequencies, adjusting the effect size to obtain the desired
variance explained, V~0:007. For each choice of the true model
size K from 1 to 8, we averaged over 1000 simulations each with
8000 individuals. In each simulation, we randomly selected K
SNPs to be ‘‘causal’’ SNPs and distributed the variance equally
across the causal SNPs, with each SNP contributing variance
V=K. The resulting model for the phenotype Y of an individual
with genotype row-vector X for the K causal SNPs is Y~
(X{m):bzu
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{V
p
, where m is the true population average of X,
b is the column-vector of SNP effects, and u is drawn from a
standard normal distribution. The resulting value for the
component of b for a causal SNP with minor allele frequency p
is b~+
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(V=K)=2p(1{p)
p
. The power was calculated as
(number of genes that are genome-wide significant)/1000, and
the error of the estimate was calculated using 95% exact binomial
confidence intervals. The p-value thresholds for genome-wide
significance came from genome-wide permutations of actual data
for GWiS, BimBam, minSNP-P and VEGAS. For LASSO,
however, the selection index threshold from the genome-wide
permutations may not be appropriate for simulations without LD.
We therefore used a slightly different approach for LASSO. We
calculated a null distribution of the selection index through
permutations, and then used this null distribution to convert the
selection index to a gene-based p-value. The p-value was then
compared to the most lenient gene-based threshold of the other
methods, 3|10{6 from minSNP-P.
(TIF)
Figure S2 Number of SNPs and effective number of tests per
gene. The number of SNPs and effective tests per gene are
displayed as a density plot for (a) chromosome 1 and (b) the
autosomal genome. While on average genes have 70 SNPs and 9
tests, large genes can have over 1000 SNPs and 100 tests.
(TIF)
Figure S3 Precision-recall curves for recovery of known
associations. Precision and recall for recovery of 38 known
associations are shown for GWiS (black), minSNP (thin blue),
minSNP-P (thick blue), BIMBAM (dashed blue), LASSO (red),
and VEGAS (green). Ranking is by p-value for GWiS, minSNP,
minSNP-P, and VEGAS, and by Selection Index for LASSO. The
tails of the curves for GWiS and LASSO are truncated when
remaining loci have no SNPs entered into models, which occurs
close to 50% recall. Triangles indicated the last genome-wide
significant finding from each method.
(TIF)
Table S1 Number of identified genome-wide significant loci.
Results are reported for 20 kb and 100 kb flanking transcription
boundaries. G: GWiS, S: minSNP, SP: minSNP-P, B: BIMBAM,
V:VEGAS, L: LASSO. *BIMBAM was only tested for 20 kb.
**VEGAS is hard-coded to use +50kb.
(PDF)
Table S2 Genome-wide significance thresholds calculated by
permutation. Results are reported for 20 kb and 100 kb flanking
transcription boundaries. Thresholds for GWiS, minSNP,
minSNP-P and VEGAS are for p-values. Threshold for LASSO
are for the selection index. The thresholds for minSNP and
LASSO decrease because the larger threshold implies more tests.
GWiS and minSNP-P already include a correction for the number
of tests within a gene, and thresholds are somewhat less stringent
for longer gene boundaries. *BIMBAM uses the threshold from
minSNP-P because both tests provide gene-based p-values with
identical uniform distributions under the null. **VEGAS is hard-
coded to use +50kb.
(PDF)
Table S3 Top associations for PR interval. The top 100
associations are reported for GWiS, minSNP, minSNP-P,
BIMBAM, VEGAS, and LASSO. The locus name concatenates
Table 3. Memory and CPU requirements.
Memory (GB) CPU time (Hours)
Method Phenotype Null Real Null Real
GWiS PR 1.2 1.2 9.4 43.1
QRS 1.2 1.2 11.0 31.9
QT 1.2 1.2 11.2 67.0
minSNP PR 0.6 0.6 13.6 62.0
QRS 0.6 0.6 15.8 45.9
QT 0.6 0.6 16.1 96.4
minSNP-P PR 0.6 0.6 11.9 54.2
QRS 0.6 0.6 13.8 40.1
QT 0.6 0.6 14.0 84.3
BIMBAM PR 0.6 0.6 14.1 42.3
QRS 0.6 0.6 16.5 33.2
QT 0.6 0.6 16.8 101.5
VEGAS PR 32.5 8.2 26.0 34.0
QRS 26.0 11.9 23.9 29.8
QT 25.8 14.1 27.1 33.0
LASSO PR 0.1 0.1 0.2 0.4
QRS 0.1 0.1 0.3 0.3
QT 0.1 0.1 0.2 0.4
The minimal memory requirement and the total CPU time to finish one
genome-wide study are reported for both a null (shuffled) trait and the real
trait. Benchmarks were obtained from AMD Operon 2.3GHz or similar
processors. The memory and CPU requirements include the model selection
and the calculation of the gene-based p-values (or selection index). Costs for
the genome-wide permutations to establish genome-wide significance
thresholds are not included in the estimates. LASSO consumes the least
resources because it pre-filters the SNPs (only uses SNPs having p-values
v0:001) and does not require permutations to calculate the selection index.
The real phenotypes require more CPU time because more permutations are
required to calculate genome-wide significant p-values for true associations.
doi:10.1371/journal.pgen.1002177.t003
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Additional columns provide the number of SNPs, the effective
number of tests, the number of independent associations within
the region (K), the p-value (P), the rank from 1 through 100, and
an indicator for known positives (isKnownPositive).
(XLS)
Table S4 Top associations for QRS interval. The column
information is the same as for Table S3.
(XLS)
Table S5 Top associations for QT interval. The column
information is the same as for Table S3.
(XLS)
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